The HarbourVest Beijing Team

Cicely Sun

Managing Director


About Cicely

Cicely Sun joined HarbourVest in 2021 and focuses on enhancing and building relationships with institutional investors and general partners in China, strengthening strategic value to the expansion of HarbourVest business in China.

Cicely joined HarbourVest from Allianz Global Investors (AGI) where she was the Managing Director, Head of China institutional business and Chairperson for AGI`s WOFE business. She was held responsible for setting the overall AGI China strategic direction and driving AGI business development effort in both private and institutional space, developed book of business and cultivated strong relationships with Chinese regulators and global stakeholders. Under her leadership, AGI was among the first batch of foreign WOFE`s obtained QDLP and PFM license and achieved important milestones for AGI in China. Cicely brings with her over 18 years of deep and broad institutional and distribution led sales and client service experience. Prior to joining AllianzGI, she has accumulated a track record covering Asia ex Japan in sales leadership positions with well-established financial institutions including State Street Global Markets in Hong Kong, Standard Chartered Bank in London and Goldman Sachs in London.

Cicely graduated from London School of Economics (LSE), UK (Msc in Finance) and Fudan University, China (Bachelor of Arts). She is a native Mandarin speaker, fluent in English, and Japanese.

Continuation solutions encompass a host of transaction types in which a GP secures interim liquidity and/or additional primary capital for their LPs in a strongly performing asset, or set of assets, that the GP will continue to own and control. Specifically, they include continuation funds, new funds created by GPs for the purpose of acquiring the asset(s) that continue to be managed by the same GP and capitalized by one or several secondary buyers, or equity recapitalizations involving a direct equity or structured equity investment into a portfolio company. These transactions can also include a parallel investment from the GP’s latest fund into that same pool of assets (a “cross-fund trade”).